• Government Announces Largest Health Care Fraud Settlement in U.S. History; GlaxoSmithKline, LLC, Enters Corporate Integrity Agreement With Novel Provisions
  • July 13, 2012 | Authors: Sheldon T. Bradshaw; John J. Delionado; Gary C. Messplay; Kyle Sampson
  • Law Firms: Hunton & Williams LLP - Washington Office ; Hunton & Williams LLP - Miami Office ; Hunton & Williams LLP - Washington Office
  • Yesterday, the U.S. Department of Justice announced that GlaxoSmithKline, LLC (“GSK”), would pay $3 billion in criminal and civil penalties to resolve multiple investigations into the company’s sales, marketing and pricing practices for nine of its drugs.